Erratum: Ambulatory blood pressure profile in hypertensive patients with ß-thalassemia minor (Hypertension Research (2011) 34, (253-256) DOI: 10.1038/hr.2010.226);Ambulatory blood pressure profile in hypertensive patients with Β-thalassemia minor

Hypertension Research

Volumn 34, Issue 2, 2011, Pages 253-256

  Vyssoulis, Gregory ^a   Karpanou, Eva ^b   Kyvelou, Stella Maria ^a   Tzamou, Vanessa ^a   Triantafyllou, Andreas ^a   Theodosiadis, George ^c   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c HIPPOKRATION HOSPITAL   (Greece)

Author keywords

ambulatory blood pressure; dipping pattern; essential hypertension; thalassemia trait

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SYSTOLIC BLOOD PRESSURE; THALASSEMIA MINOR;

EID: 79751489347     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2012.49     Document Type: Erratum

References (32)

1. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Reboldi G. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801. (Pubitemid 24363980)
2. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46: 156-161. (Pubitemid 40946507)
3. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415. (Pubitemid 36682819)
4. Mancia G, Parati G. The role of blood pressure variability in end-organ damage. J Hypertens Suppl 2003; 21: 17-23.
5. White WB. Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens Suppl 2003; 21: 9-15.
6. Pickering T. Future developments in ambulatory blood pressure monitoring and selfblood pressure monitoring in clinical practice. Blood Press Monit 2002; 7: 21-25. (Pubitemid 34304047)
7. Cuspidi C, Macca G, Sampieri L, Fusi V, Severgnini B, Michev I, Salerno M, Magrini F, Zanchetti A. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens 2001; 19: 1539-1545. (Pubitemid 32783770)
8. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536. (Pubitemid 20055961)
9. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990; 16: 692-699.
10. Covic A, Haydar AA, Goldsmith DJ. Recent insights from studies using ambulatory blood pressure monitoring in patients with renal disease. Curr Opin Nephrol Hypertens 2003; 12: 645-648. (Pubitemid 38186757)
11. Rahman M, Griffin V, Heyka R, Hoit B. Diurnal variation of blood pressure; reproducibility and association with left ventricular hypertrophy in hemodialysis patients. Blood Press Monit 2005; 10: 25-32. (Pubitemid 40316149)
12. Goto N, Uchida K, Morozumi K, Ueki T, Matsuoka S, Katayama A, Haba T, Tominaga Y, Fukuda M, Nakao A, Kimura G. Circadian blood pressure rhythm is disturbed by nephrectomy. Hypertens Res 2005; 28: 301-306. (Pubitemid 40895051)
13. Karimi M, Ghavanini A, Kadivar MR. Regional mapping of the gene frequency of b-thalassemia in Fars province, Iran during 1997-1998. Iran J Med Sci 2000; 25: 134-137.
14. Maioli M, Pettinato S, Cherchi GM, Giraudi D, Pacifico A, Pupita G, Tidore MG. Plasma lipids in b-thalassemia minor. Atherosclerosis 1989; 75: 245-248.
15. Fessas P, Stamatoyannopoulous G, Keys A. Serum cholesterol and thalassemia trait. Lancet 1963; 1: 1182-1183.
16. Botliger LE, Carlson LA. Relation between serum cholesterol and triglyceride concentration and hemoglobin values in non-anemic healthy persons. BMJ 1972; 3: 731-733.
17. Gallerani M, Scapldi C, Cicognani I, Ricci A, Martinelli L, Cappato R, Manfredini R, Dall'Ara G, Faggioli M, Pareschi PL. Thalassemia trait and myocardial infarction: low infarction incidence in male subjects confirmed. J Inter Med 1991; 230: 109-111.
18. Crowley JP, Sheth S, Capone RJ, Schilling RF. A paucity of thalassemia trait in Italian men with myocardial infarction. Acta Haematol 1987; 78: 249-251. (Pubitemid 18037211)
19. Wang CH, Schilling RF. Myocardial infarction and thalassemia trait: an example of heterozygote advantage. Am J Hematol 1995; 49: 73-75.
20. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, Leonetti G, Magrini F, Zanchetti A. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 1991-1998. (Pubitemid 39336683)
21. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA, Viigimaa M, Zanchetti A. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009; 18: 308-347.
22. Scott MD, Van den Berg JJM, Repka T, Rouyer-Fessard Ph, Hebbel RP, Beuzard Y, Lubin B. Effect of excess a-hemoglobin chains on cellular and membrane oxidation in model b-thalassemic erythrocytes. J Clin Invest 1993; 91: 1706-1712. (Pubitemid 23127376)
23. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992; 13: 341-390.
24. Gillum RF. Body iron stores and atherosclerosis. Circulation 1997; 96: 3261-3263. (Pubitemid 27513389)
25. Altamentova SM, Marva E, Shaklai N. Oxidative interaction of unpaired hemoglobin chains with lipids and proteins: a key for modified serum lipoproteins in thalassemia. Arch Biochem Biophys 1997; 345: 39-46. (Pubitemid 27374206)
26. Karimi M, Marvasti VE, Motazedian S, Sharifian M. Is b-thalassemia trait a protective factor against hypertension in young adults? Ann hematol 2006; 85: 29-31. (Pubitemid 41782422)
27. Namazi M. Minor thalassemia as a protective factor against cerebrovascular accidents. Med Hypotheses 2002; 59: 361-362.
28. Cavelaars M, Tulen JH, van Bemmel JH, Mulder PG, van den Meiracker AH. Reproducibility of intra-arterial ambulatory blood pressure: effects of physical activity and posture. J Hypertens 2004; 22: 1105-1112. (Pubitemid 38721001)
29. O'Shea JC, Murphy MB. Nocturnal blood pressure dipping: a consequence of diurnal physical activity blipping? Am J Hypertens 2000; 13: 601-606. (Pubitemid 30459870)
30. Duke M, Abelmann WH. The hemodynamic response to chronic anemia. Circulation 1969; 39: 503-515.
31. Anand IS, Chandrashekhar Y, Ferrari R, Poole-Wilson PA, Harris PC. Pathogenesis of oedema in chronic severe anemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993; 70: 357-362. (Pubitemid 23309546)
32. Vyssoulis G, Karpanou E, Kyvelou S-M, Tzamou V, Theodosiadis G, Stefanadis C. Ambulatory blood pressure profile in anemic hypertensive patients. Int J Cardiol 2009; .6. [e-pub ahead of print].